|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 31/00 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3630177 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18728153.0 |
| Date of filing the European patent application | 2018-05-30 | |
| (97) | Date of publication of the European application | 2020-04-08 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-09 |
| (46) | Date of publication of the claims translation | 2023-10-25 |
| (86) | Number | PCT/EP2018/064229 |
| Date | 2018-05-30 |
| (87) | Number | WO 2018/220040 |
| Date | 2018-12-06 |
| (30) | Number | Date | Country code |
| 17173712 | 2017-05-31 | EP |
| (72) |
KELEMEN, Peter , DE
SCHWARZ, Michael , DE
WINDERLICH, Mark , DE
HEEGER, Steffen , DE
WEINELT, Dominika , DE
|
| (73) |
Incyte Corporation ,
1801 Augustine Cut-Off, Wilmington, Delaware 19803,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Gydymo paradigma, skirta kompleksiniam gydymui anti-CD19 antikūnu ir venetoklaksu |
| TREATMENT PARADIGM FOR AN ANTI-CD19 ANTIBODY AND VENETOCLAX COMBINATION TREATMENT |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 8 | 185.00 EUR |
| 2026-05-30 |